A detailed history of Peak6 Investments LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Peak6 Investments LLC holds 2,000 shares of BMRN stock, worth $133,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$133,260
Previous $164,000 14.63%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$69.02 - $93.84 $400,316 - $544,272
-5,800 Reduced 48.96%
6,047 $425,000
Q2 2024

Aug 13, 2024

BUY
$74.43 - $92.22 $881,772 - $1.09 Million
11,847 New
11,847 $975,000
Q2 2023

Aug 11, 2023

SELL
$86.68 - $100.3 $692,053 - $800,795
-7,984 Reduced 69.7%
3,470 $300,000
Q1 2023

May 12, 2023

BUY
$87.74 - $117.27 $1 Million - $1.34 Million
11,454 New
11,454 $1.11 Million
Q2 2022

Aug 12, 2022

BUY
$71.48 - $86.85 $323,732 - $393,343
4,529 New
4,529 $375,000
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $15,673 - $19,557
-211 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$71.72 - $91.47 $4.87 Million - $6.2 Million
-67,834 Reduced 99.69%
211 $19,000
Q3 2021

Nov 12, 2021

BUY
$74.77 - $85.47 $1.92 Million - $2.19 Million
25,629 Added 60.42%
68,045 $5.26 Million
Q2 2021

Aug 13, 2021

SELL
$75.51 - $84.79 $2.19 Million - $2.46 Million
-28,996 Reduced 40.6%
42,416 $3.54 Million
Q1 2021

May 14, 2021

BUY
$74.73 - $90.69 $5.17 Million - $6.28 Million
69,196 Added 3122.56%
71,412 $5.39 Million
Q4 2020

Feb 12, 2021

SELL
$72.61 - $90.2 $435,514 - $541,019
-5,998 Reduced 73.02%
2,216 $194,000
Q3 2020

Nov 13, 2020

BUY
$71.87 - $131.03 $499,712 - $911,051
6,953 Added 551.39%
8,214 $624,000
Q1 2020

May 14, 2020

SELL
$71.37 - $96.85 $307,390 - $417,132
-4,307 Reduced 77.35%
1,261 $107,000
Q4 2019

Feb 13, 2020

SELL
$64.27 - $86.37 $2.7 Million - $3.63 Million
-41,991 Reduced 88.29%
5,568 $471,000
Q3 2019

Nov 08, 2019

BUY
$67.4 - $85.11 $2.27 Million - $2.87 Million
33,750 Added 244.41%
47,559 $3.21 Million
Q2 2019

Aug 14, 2019

SELL
$80.35 - $93.9 $2.42 Million - $2.83 Million
-30,144 Reduced 68.58%
13,809 $1.18 Million
Q4 2018

Feb 13, 2019

SELL
$80.14 - $106.07 $1.43 Million - $1.9 Million
-17,877 Reduced 28.91%
43,953 $3.74 Million
Q3 2018

Nov 13, 2018

BUY
$93.92 - $105.72 $5.81 Million - $6.54 Million
61,830 New
61,830 $6 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.